PP 9706642

Drug Profile

PP 9706642

Alternative Names: PP9706642; Viracure - Piramal

Latest Information Update: 23 Jun 2015

Price : $50

At a glance

  • Originator Piramal Healthcare
  • Developer Piramal Enterprises
  • Class Antivirals; Herbal medicines; Phytotherapies
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Herpes simplex virus type 2 infections

Most Recent Events

  • 09 Jun 2012 Piramal Life Sciences completes a phase II trial in Herpes simplex virus type-2 infections in India (CTRI/2011/05/001706)
  • 09 May 2011 Phase-II clinical trials in Herpes simplex virus type-2 infections in India (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top